Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products.
Financial Results:
NGL Fine Chem Ltd reported Revenues for Q1FY24 of ₹69.11 Crores up from ₹63.58 Crore year on year, a rise of 8.7%.
Total Expenses for Q1FY24 of ₹63.75 Crores down from ₹65.93 Crores year on year, a fall of 3.31%.
Consolidated Net Profit of ₹7.81 Crores up 1431.37% from ₹0.51 Crores in the same quarter of the previous year.
The Earnings per Share is ₹12.64, up 1,422.89% from ₹0.83 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.